LSU Health New Orleans signs deal with biosciences startup

(Louisiana State University Health Sciences Center) The Office of Technology Management at LSU Health New Orleans has finalized a deal with CB BioSciences, Inc., a startup drug development company to build a platform around the intellectual property portfolio of Chu Chen, Ph.D., LSU Health New Orleans Professor of Neuroscience. Dr. Chen's research has focused on identifying the mechanisms responsible for the unwanted adverse effects associated with Δ9-THC, one of the cannabinoids with the most ...